Literature DB >> 7582565

Inhibition of the centrally induced increases in myocardial oxygen demand in rabbits by chronic treatment with baclofen, a selective GABAB agonist.

E Tibiriçà1, M Catelli, M A Lessa, J C Roegel, J Feldman, L Monassier, P Bousquet.   

Abstract

1. A previous study from our group demonstrated that neurones of the paraventricular nucleus of the hypothalamus (PVN) are selectively involved in the central control of the cardiac function. Moreover, in that study, it was shown that baclofen, a selective GABAB receptor agonist, is capable of modulating the increases in myocardial contractility and oxygen demand evoked by electrical or pharmacological stimulation of the PVN. Nevertheless, the acute administration of this compound was frequently accompanied by a cardiodepressant effect. 2. In the present study, the effects of a long term treatment (14 days) with baclofen (3 or 10 mg kg-1, i.p.) have been examined on the excitatory haemodynamic responses evoked by central pharmacological stimulation in anaesthetized rabbits. 3. The i.c.v. injection of L-glutamate (3 mg kg-1) induced marked increases in dP/dtmax (32%), mean arterial pressure (39%) and on two indices of myocardial oxygen consumption: the rate-pressure product (34%) and the triple product (78%). 4. Baclofen blunted the positive inotropic response and the increases in myocardial oxygen consumption induced by L-glutamate in a dose-related manner. The higher dose of baclofen (10 mg kg-1, i.p.), reduced by more than 50% these excitatory effects of L-glutamate without eliciting any significant negative effect on basal haemodynamics. The same doses of baclofen were not able to blunt the hypertensive response induced by central stimulation. 5. These results confirm and extend our previous findings suggesting that it is possible to discriminate the central control of vasomotor tone from that of cardiac function and also that baclofen can modulate the latter. It is concluded that when given chronically, baclofen modulates the increases in myocardial oxygen demand induced by activation of the central nervous system in doses which do not depress the resting cardiac function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582565      PMCID: PMC1908785          DOI: 10.1111/j.1476-5381.1995.tb15045.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Baclofen: a selective agonist for a novel type of GABA receptor proceedings.

Authors:  N G Bowery; A Doble; D R Hill; A L Hudson; J S Shaw; M J Turnbull
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

2.  Action of baclofen on mammalian synaptic transmission.

Authors:  S Fox; K Krnjević; M E Morris; E Puil; R Werman
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

3.  Action of a GABA-derivative on postsynaptic potentials and membrane properties of cats' spinal motoneurones.

Authors:  F K Pierau; P Zimmermann
Journal:  Brain Res       Date:  1973-05-17       Impact factor: 3.252

4.  Baclofen: stereoselective inhibition of excitant amino acid release.

Authors:  G A Johnston; M H Hailstone; C G Freeman
Journal:  J Pharm Pharmacol       Date:  1980-03       Impact factor: 3.765

5.  Validity of myocardial oxygen consumption parameters.

Authors:  D Baller; H J Bretschneider; G Hellige
Journal:  Clin Cardiol       Date:  1979-10       Impact factor: 2.882

6.  (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

Authors:  N G Bowery; D R Hill; A L Hudson; A Doble; D N Middlemiss; J Shaw; M Turnbull
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

7.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

8.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

9.  Neural and psychologic mechanisms and the problem of sudden cardiac death.

Authors:  B Lown; R L Verrier; S H Rabinowitz
Journal:  Am J Cardiol       Date:  1977-05-26       Impact factor: 2.778

10.  Effects of beta-(p-chlorophenyl)-GABA (baclofen) on spinal synaptic activity.

Authors:  H Fukuda; Y Kudo; H Ono
Journal:  Eur J Pharmacol       Date:  1977-07-01       Impact factor: 4.432

View more
  3 in total

1.  Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats.

Authors:  A Grabe-Guimarães; L M Alves; E Tibiriçá; A C Nóbrega
Journal:  Clin Auton Res       Date:  1999-04       Impact factor: 4.435

2.  Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats.

Authors:  David Czell; Turgay Efe; Matthias Preuss; Markus D Schofer; Ralf Becker
Journal:  Neurochem Res       Date:  2011-10-09       Impact factor: 3.996

3.  Cardioprotective Effects of Remifentanil in a Sympathetic Hyperactivity Model in Rabbits.

Authors:  Selen Bayındır; Necati Gökmen; Serhat Erbayraktar; Semih Küçükgüçlü; Osman Yılmaz; Ömer Şahin; Elvan Öçmen; Hale Aksu Erdost; Emel Sağıroğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.